Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event …

C Lam, E Meinert, A Yang, Z Cui - Cytotherapy, 2021 - Elsevier
Background aims Decentralized, or distributed, manufacturing that takes place close to the
point of care has been a manufacturing paradigm of heightened interest within the cell …
被引用次数：29 相关文章

Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event …

C Lam, E Meinert, A Yang, Z Cui - Cytotherapy, 2021 - europepmc.org
Methods To compare the operational feasibility and cost implications of manufacturing
autologous chimeric antigen receptor T (CAR T)-cell products between centralized and …

Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event …

C Lam, E Meinert, A Yang, Z Cui - Cytotherapy, 2021 - pubmed.ncbi.nlm.nih.gov
Background aims Decentralized, or distributed, manufacturing that takes place close to the
point of care has been a manufacturing paradigm of heightened interest within the cell …